Spelling suggestions: "subject:"oral contraceptive"" "subject:"oral contraception""
31 |
Effecten van een oraal contraceptivum bij de rhesusaap een morfologisch en biochemisch onderzoek /Vooijs, Gijsbert Peter. January 1971 (has links)
Thesis--University of Nijmegen. / Summary in English and Dutch. Includes bibliographical references (p. 101-108).
|
32 |
Hormone status and measures of joint laxitySmith, Krystal January 2007 (has links) (PDF)
Thesis (M.S.)--University of North Carolina at Greensboro, 2007. / Title from PDF t.p. (viewed Oct. 22, 2007). Directed by Sandra Shultz; submitted to the School of Health and Human Performance. Includes bibliographical references (p. 77-84).
|
33 |
Relationship between menstrual cycle phases and cognitive function in femalse [sic] who use and do not use oral contraceptivesCockerell, Meredith G. January 2008 (has links)
Thesis (M.S.)--Michigan State University, 2008. / Includes bibliographical references (leaves 49-52).
|
34 |
Insulin resistance in polycystic ovary syndromeMorin-Papunen, L. (Laure) 15 August 2000 (has links)
Abstract
The polycystic ovary syndrome, described first as the association
of bilateral polycystic ovaries and amenorrhoea, oligomenorrhoea,
hirsutism and obesity, was later shown to be a complex metabolic syndrome.
The first purpose of this study was to investigate the occurrence
of hyperinsulinaemia and the severity of insulin resistance and
glucose tolerance disorders in polycystic ovary syndrome by means of
the oral glucose tolerance test and the euglycaemic hyperinsulinaemic
clamp. The next goal was to investigate whether women with polycystic
ovary syndrome would benefit from insulin-sensitising drugs, and
in particular to compare the effects of metformin and a contraceptive
pill containing ethinyl oestradiol and cyproterone acetate. Altogether,
81 women with polycystic ovary syndrome and 34 healthy control subjects
were involved in the study.
Marked impairment of insulin sensitivity in obese subjects
with polycystic ovary syndrome, including a decrease of both cellular
oxidative and non-oxidative utilisation of glucose, and a slight non-significant
decrease of insulin sensitivity in non-obese subjects was observed.
Both non-obese and obese subjects with polycystic ovary syndrome
exhibited increased abdominal obesity compared with the controls,
confirming the fact that obesity, in particular abdominal obesity,
is an important contributor in the development of insulin resistance
in this syndrome.
Metformin alleviated hyperandrogenism by essentially decreasing
ovarian, but not adrenal androgen secretion. The improvement of
hyperandrogenism and ovarian function seemed to be mediated by the
improvement of hyperinsulinaemia, which resulted itself from subtle
improvements in both hepatic insulin extraction and insulin sensitivity.
Metformin decreased abdominal obesity and the release of free fatty
acids from adipose tissue, and improved ovarian cyclicity and fertility.
The transient decrease in serum leptin levels observed may have
some role in the improvement of ovarian function. The contraceptive
pill significantly improved hyperandrogenism and hirsutism, and
it slightly affected glucose metabolism. Thus, it could be the treatment
of choice in women with hirsutism problems and no fertility hopes.
Metformin could be the drug of choice for women with polycystic
ovary syndrome who wish to conceive. Because of its beneficial metabolic
effects, the value of metformin in reducing the risk of cardiovascular
diseases in polycystic ovary syndrome needs to be further studied.
|
35 |
Testosterone and cognitive aspects of sexual behavior in women and menAlexander, Gerianne M. January 1990 (has links)
No description available.
|
36 |
THE EFFECT OF LONG-TERM ORAL CONTRACEPTIVE THERAPY PRIOR TO PREGNANCY ON MATERNAL AND FETAL ZINC STATUS.Beard, Lisa Powell. January 1983 (has links)
No description available.
|
37 |
The effect of oral contraceptives on musculo-tendinous stiffness of the knee flexorsColthrust, Melissa B. January 2005 (has links)
The purpose of this study is to investigate the relationship between oral contraceptive use and the musculo-tendinous stiffness of the knee flexors. Twenty-three female participants and ten male participants (control group) ranging in age from 20 - 30 years. A uniaxial accelerometer was used to assess stiffness based on the exponential decay of the damped oscillation. Female groups had estradiol and 17 a-OH progesterone levels tested. At 30% of MVC, the Ortho-Tri Cyclen group, the Other OC group and women not using OC's had a mean stiffness of 249.3+94.5, 274.1+79.1 and 216.0+43.3 Nm/rad respectively and at 50% of MVC values of 290.2+70.7, 326.7+78.9 and 267.9+52.6 Nm/rad respectively. No significant difference in stiffness was found. Also no correlation was found between estradiol and stiffness. These results indicate that there was no significance between knee stiffness and oral contraceptives within the female groups. / School of Physical Education, Sport, and Exercise Science
|
38 |
Diet, hormones and breast cancer : a case-control study in women /Rohan, Thomas Edward. January 1986 (has links) (PDF)
Thesis (Ph. D.)--University of Adelaide, Dept. of Community Medicine, 1986? / Includes bibliographical references (v. 2, leaves [410]-464).
|
39 |
Effects of dietary restraint and oral contraceptives on bone strength and bone turnover in young womenDiGiovanni, Gioia. January 1900 (has links)
Thesis (M.S.)--Brock University, 2006. / Includes bibliographical references (leaves 97-126).
|
40 |
The effect of boron supplementation and oral contraceptives on mineral status and hormone status of college female athletes and non-atheletes /Ward, Candice Lyn, January 1994 (has links)
Thesis (M.S.)--Virginia Polytechnic Institute and State University, 1994. / Vita. Abstract. Includes bibliographical references (leaves 124-142). Also available via the Internet.
|
Page generated in 0.0979 seconds